Eltrombopag Olamine Tablets 25 mg

LTROLAMINE 25 is a prescription medicine containing Eltrombopag Olamine Tablets 25 mg, widely used in the management of low platelet count (thrombocytopenia). It belongs to a class of medicines known as thrombopoietin receptor agonists, which help stimulate platelet production in the bone marrow. LTROLAMINE 25 is commonly prescribed in patients suffering from chronic immune thrombocytopenia (ITP), hepatitis Cassociated thrombocytopenia, and certain bone marrow disorders. This medicine plays a vital role in reducing the risk of bleeding by maintaining a healthy platelet count, especially in patients who do not respond adequately to conventional treatments.

Uses

Eltrombopag Olamine Tablets 25 mg are primarily used for the following medical conditions:

• Treatment of chronic immune thrombocytopenia (ITP) in adults and children who have had insufficient response to corticosteroids, immunoglobulins, or splenectomy

• Management of thrombocytopenia in patients with chronic hepatitis C, enabling continuation of antiviral therapy

• Treatment of severe aplastic anemia in patients who are refractory to immunosuppressive therapy

LTROLAMINE 25 helps improve platelet levels and reduces bleeding complications in these conditions.

Benefits

LTROLAMINE 25 offers several clinical and patient-focused benefits:

• Promotes increased platelet production by stimulating bone marrow activity

• Helps reduce the risk of bleeding and bruising associated with low platelet counts

• Enables patients with hepatitis C to continue antiviral treatment safely

• Useful in long-term management of chronic thrombocytopenia

• Oral tablet form ensures easy administration and better patient compliance

With regular monitoring and correct dosage, LTROLAMINE 25 supports improved quality of life for patients with platelet disorders.

Dosage

The dosage of LTROLAMINE 25 should be strictly determined by a healthcare professional based on the patients medical condition, platelet count, age, and response to treatment.

• Usually taken once daily on an empty stomach, at least 1 hour before or 2 hours after meals

• Should not be taken with dairy products, calcium supplements, or antacids, as they may reduce absorption

• Regular blood tests are required to monitor platelet levels and liver function

Patients should never adjust the dose or stop the medication without consulting their doctor.

Side Effects

Like all medicines, Eltrombopag Olamine Tablets 25 mg may cause some side effects, although not everyone experiences them. Commonly reported side effects include:

• Headache

• Nausea or vomiting

• Fatigue

• Diarrhea

• Upper respiratory tract infections

Less common but serious side effects may include liver function abnormalities, blood clots, or changes in blood counts. Immediate medical attention is advised if any unusual symptoms occur.

Precautions and Warning

Before starting LTROLAMINE 25, patients should inform their doctor about their complete medical history. Important precautions include:

• Use with caution in patients with liver disease

• Regular monitoring of liver enzymes and platelet count is essential

• Not recommended during pregnancy or breastfeeding unless clearly advised by a physician

• Risk of thromboembolic events if platelet levels rise excessively

• Avoid taking with iron, calcium, magnesium, or aluminum-containing products close to dosing time

LTROLAMINE 25 should be used only under medical supervision.

Conclusion

LTROLAMINE 25, containing Eltrombopag Olamine Tablets 25 mg, is an effective and clinically proven option for managing thrombocytopenia associated with chronic immune disorders, hepatitis C, and aplastic anemia. By stimulating platelet production, it helps reduce bleeding risks and supports long-term disease management. When taken as prescribed and monitored regularly, LTROLAMINE 25 offers a reliable solution for patients requiring safe and effective platelet count improvement.